Exopert
Clinical trials sponsored by Exopert, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New blood test uses AI and lasers to spot High-Risk breast cancer Results expected Dec 2026 (estimated)
-
New blood test uses AI and lasers to spot High-Risk breast cancer
Diagnosis Recruiting nowThis study is testing a new blood test that uses laser technology and artificial intelligence to help doctors tell apart high-risk and low-risk breast cancer patients. About 330 people with breast cancer will give a blood sample before treatment. The test looks at tiny particles …
Sponsor: EXoPERT • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
AI-Powered blood test could spot five cancers before symptoms show
Diagnosis Recruiting nowThis study is testing a new blood test called EXoPred that uses artificial intelligence and laser technology to find tiny particles from cancer cells. The goal is to detect breast, colon, pancreatic, ovarian, and lung cancers at an early stage. Researchers will enroll 1,400 peopl…
Sponsor: EXoPERT • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC